Joint Management Entrance Test

BeautyFarm Med, the largest provider of traditional beauty services in China Successfully Listed on the Main Board of SEHK

Retrieved on: 
星期二, 一月 17, 2023
Joint, Motherboard, Marketing, Publicis Healthcare Communications Group, Neology, Stock exchange, HK, Joint Management Entrance Test, Property management

The stock price of BeautyFarm Med reached HK$30.5 at its debut today, representing an increase of 57.9% over the offer price.

Key Points: 
  • The stock price of BeautyFarm Med reached HK$30.5 at its debut today, representing an increase of 57.9% over the offer price.
  • BeautyFarm Med is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China with a market share of 0.2% and 0.6%, respectively, as measured by revenue in 2021 and according to Frost & Sullivan.
  • The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology.
  • The service offerings of the Company cover traditional beauty services, aesthetic medical services as well as subhealth assessment and intervention services, across the full client lifecycle.

Cool Company Ltd. formation update

Retrieved on: 
星期四, 一月 20, 2022
Securities Exchange Act of 1934, Oslo, IPO, DNB ASA, Joint Management Entrance Test, Danske bankas, ABG, EPS, LNG, FSRU, Acquisition, Security (finance), Golar Spirit, Nordea

Golar LNG (Golar) is pleased to provide an update on the formation of Cool Company Ltd. (CoolCo).

Key Points: 
  • Golar LNG (Golar) is pleased to provide an update on the formation of Cool Company Ltd. (CoolCo).
  • As part of the transaction CoolCo plans to raise around $250 million of external equity through a private placement of equity (Private Placement).
  • The formation of CoolCo is expected to be concluded within Q1 2022 subject to market conditions.
  • Golar LNG Limited undertakes no obligation to update publicly any forward-looking statements whether as a result of new information, future events or otherwise, unless required by applicable law.